Trials / Completed
CompletedNCT01895517
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）
Randomized Controlled Trial to Evaluate the Efficacy of Concurrent Liquid-based Cytology ( LBC) and HPV DNA Testing Versus LBC Alone for the Primary Cervical Cancer Screening
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18,471 (actual)
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
- Sex
- Female
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LBC | Cervical cancer screening by using liquid based cytology as a standard screening modality |
| OTHER | LBC plus HPV DNA testing | Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality |
Timeline
- Start date
- 2013-06-07
- Primary completion
- 2022-11-30
- Completion
- 2023-05-31
- First posted
- 2013-07-10
- Last updated
- 2023-06-26
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01895517. Inclusion in this directory is not an endorsement.